The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Regulatory

Coming back to: Research-use-only labelling: what it means and what it does not

Solved
Solved by i.bakken in post #6
The arithmetic in post #3 is right; the assumption feeding it is the part to check. Offering a way to settle Research-use-only labelling rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise, the question was not answerable at this…

Jump to the accepted answer →

RD
r.danquahTL22 Oct 2024#1

Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable.

A labelling question, and I would like the answer to be about what the words mean rather than about what people do.

"Research use only" appears on the vial and on the paperwork. Research-use-only material is not approved for human use in any jurisdiction I am aware of, and I am asking about the classification itself: what it obliges the seller to do, what it obliges the buyer to do, and what it says about the material.

I would rather have the narrow, accurate answer than the broad, comfortable one.

18 likes 22mo
CC
c.correiaTL25 Oct 2024#2

Narrowing the opening post, because the general version has more than one answer.

My position on Research-use-only labelling is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

2 likes 22mo
AA
a.almeidaTL28 Oct 2024#3

Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The label does not establish whether the molecule is safe, efficacious, or toxic.

I have deliberately not rounded that, because the rounding is where the argument starts.

0 likes 22mo
PS
p.silvaTL210 Oct 2024#4

If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.

I have no interest in any supplier named above.

29 likes 22mo
DO
dr_okonkwoTL412 Oct 2024#5
IB
i.bakkenTL2 Solution14 Oct 2024#6
dr_okonkwo, post #5: Second-hand on Research-use-only labelling, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself. Go to post

The arithmetic in post #3 is right; the assumption feeding it is the part to check.

Offering a way to settle Research-use-only labelling rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise, the question was not answerable at this precision.

8 likes in reply to #5 21mo
DF
d.fontaineTL215 Oct 2024#7

Where I part company with post #3, and it is a narrow parting.

Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.

0 likes 21mo
KS
k.salinasTL217 Oct 2024#8

Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only compounds, which are not approved for any human use.

21 likes 21mo
VS
v.szaboTL3Analytical chemist19 Oct 2024#9

Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.

I have said this before in a thread nobody could find, so it is worth repeating.

3 likes 21mo
OV
o.vukovicTL220 Oct 2024#10
v.szabo, post #9: Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. I have said this before in a thread nobody could find, so it is worth repeating. Go to post

Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling tells you the intended use, not the actual use people make of it.

The uncertainty is in the assumption, not in the calculation.

0 likes in reply to #9 21mo
RV
r.venkatesanTL3Wiki editor22 Oct 2024#11

Practical experience of Research-use-only labelling, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

22 likes 21mo
PK
p.krastevTL223 Oct 2024#12
d.fontaine, post #7: Where I part company with post #3, and it is a narrow parting. Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Go to post

Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.

Posted with less confidence than the sentence structure implies.

0 likes in reply to #7 21mo
MM
maintenance_modeTL3Regular25 Oct 2024#13

Fair, and the limits you put on it are the part I will remember.

1 like 21mo
FD
f.danquahTL226 Oct 2024#14
LE
logbook_erinTL3Regular27 Oct 2024#15

An observation about Research-use-only labelling that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.

15 likes 21mo
AP
au.pereiraTL229 Oct 2024#16

Post #15 describes the usual case. This is about the unusual one.

An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.

30 likes 21mo
CL
coldchain_liuTL3Regular30 Oct 2024 · edited#17
r.danquah, post #1: Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. A labelling question, and I would like the answer to be about what the words mean rather than about what people do. "Research use only" appears on the vial and on the paperwork. Research-use-only material… Go to post

Confirming post #16 from a second method, which matters more than confirming it from a second person.

The claim about Research-use-only labelling upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

0 likes in reply to #1 21mo
AI
a.ilungaTL21 Nov 2024#18

My understanding of Research-use-only labelling is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

3 likes 21mo
HA
h.almeidaTL22 Nov 2024#19
TM
t.marchettiTL23 Nov 2024#20

Quietly grateful for the plain phrasing. Not every thread gets that.

0 likes 21mo
SK
s.kuuselaTL25 Nov 2024#21
maintenance_mode, post #13: Fair, and the limits you put on it are the part I will remember. Go to post

I would call the community position on Research-use-only labelling likely rather than established, and I would be comfortable defending that hedge.

31 likes in reply to #13 21mo
B
batchlogTL3Regular6 Nov 2024#22
v.szabo, post #9: Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. I have said this before in a thread nobody could find, so it is worth repeating. Go to post

The arithmetic in post #21 is right; the assumption feeding it is the part to check.

Research-use-only labelling is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

16 likes in reply to #9 21mo
DF
d.ferreiraTL27 Nov 2024 · edited#23

I had read the opposite somewhere and cannot now find where, which tells me something.

3 likes 21mo
BV
bias_varianceTL4Biostatistician8 Nov 2024#24

Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.

I would want to see it done twice before believing it once.

0 likes 21mo
YA
y.adeyemiTL210 Nov 2024#25

Post #24 describes the usual case. This is about the unusual one.

Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality.

0 likes 21mo
MM
maintenance_modeTL3Regular11 Nov 2024#26
maintenance_mode, post #13: Fair, and the limits you put on it are the part I will remember. Go to post

Adding the measurement that post #24 says would settle it.

What I can speak to on Research-use-only labelling is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.

22 likes in reply to #13 21mo
GR
g.radichTL212 Nov 2024#27

If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.

This is the sort of thing that ought to be settled and apparently is not.

6 likes 20mo
TY
two_year_lineTL3Regular13 Nov 2024#28

One more thing on Research-use-only labelling that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

1 like 20mo
PT
p.trevinoTL215 Nov 2024#29

Two people in this thread mean different things by Research-use-only labelling and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.

17 likes 20mo
IS
isotonic_sheetTL3Regular16 Nov 2024#30

Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported.

I would not lead a decision with this, but I would not ignore it either.

6 likes 20mo